Research
Hormonal
TLR4 deficiency protects mice from diet-induced obesity and improves insulin sensitivity, although effects on body weight are contradictory across studies.
Immune system activation via Toll-like receptors (specifically TLR4) by dietary saturated fats may drive insulin resistance and inflammation associated with obesity. While genetic modification of TLR4 shows benefits in mice, this highlights the importance of managing saturated fat intake to reduce inflammatory signaling.
ModerateQualifiesMEDIUM confidence
TLR4, being expressed in most tissues of the body... appears to be an essential mediator of bodily insulin-resistance... mice genetically deficient in TLR4... were reported to be of 'ideal body type'... However, this approach has to be considered with caution since contradictory results have been obtained with high-fat-fed TLR4-deficient mice.
Why this rating
Review of animal models with conflicting results on weight but consistent findings on insulin sensitivity.
Source
Feeding Our Immune System: Impact on Metabolism
Isabelle Wolowczuk et al. · Clinical and Developmental Immunology · 2008
DOI 10.1155/2008/639803
narrative_reviewCited 297×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
- Glucose is the primary fuel source for immune cells, with activation leading to a rapid increase in glucose consumption and glycolysis, similar to insulin-responsive adipose tissue.Good
- Saturated fatty acids activate Toll-like receptors (TLR2 and TLR4) on immune and adipose cells, triggering proinflammatory cytokine production (TNF-α, IL-6) and contributing to insulin resistance, whereas unsaturated fatty acids inhibit this signaling.Moderate
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →